Top Section/Ad
Top Section/Ad
Most recent
DocMorris announces Sfr200m rights issue expected in May
Stock drops 17% in highly volatile market
Deal follows steep share price fall
More articles/Ad
More articles/Ad
More articles
-
PE firm Quadria is looking to trim its stake in the Indian biopharmaceutical company -
-
Smaller, privately owned companies are becoming a key part of the local IPO market
-
Government interventions staved off pandemic-related defaults, though macro headwinds are causing uncertainty
-
Verona Pharma and Borr Drilling raise capital at opportune moment
-
Finances drug company's buyout by Carlyle and PAI Partners
